CIK 0001619856
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Caribou Biosciences, Inc.
Sign in to watch- Ticker
- CRBU
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453728228
- Phone
- +1 510-982-6030
- Business address
- 2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-21 | Kanner Steven Chief Scientific Officer | Sale | −3,564 | $1.35 | $5K | 431,556 |
| 2025-02-20 | Kanner Steven Chief Scientific Officer | Grant or award | +37,500 | 435,120 | ||
| 2025-02-20 | Kanner Steven Chief Scientific Officer | Grant or award · Option to purchase Common Stock | +170,000 | 170,000 | ||
| 2024-02-20 | Kanner Steven Chief Scientific Officer | Grant or award | +33,000 | 387,037 | ||
| 2024-02-20 | Kanner Steven Chief Scientific Officer | Grant or award · Option to purchase Common Stock | +153,000 | 153,000 | ||
| 2024-02-06 | Kanner Steven Chief Scientific Officer | Option exercise | +30,577 | $2.69 | $82K | 354,037 |
| 2024-02-06 | Kanner Steven Chief Scientific Officer | Option exercise · Option to purchase Common Stock | −30,577 | 21,623 | ||
| 2023-02-21 | Kanner Steven Chief Scientific Officer | Grant or award · Option to purchase Common Stock | +131,000 | 131,000 | ||
| 2022-12-02 | Kanner Steven Chief Scientific Officer | Option exercise | +21,401 | $2.69 | $58K | 323,460 |
| 2022-12-02 | Kanner Steven Chief Scientific Officer | Option exercise · Option to purchase Common Stock | −21,401 | $2.69 | $58K | 52,200 |
| 2022-08-25 | Kanner Steven Chief Scientific Officer | Option exercise | +43,248 | $2.69 | $116K | 345,307 |
| 2022-08-25 | Kanner Steven Chief Scientific Officer | Sale | −43,248 | $11.22 | $485K | 302,059 |
| 2022-08-25 | Kanner Steven Chief Scientific Officer | Option exercise · Option to purchase Common Stock | −43,248 | 73,601 | ||
| 2022-05-13 | Kanner Steven Chief Scientific Officer | Option exercise | +68,306 | $1.81 | $124K | 295,945 |
| 2022-05-13 | Kanner Steven Chief Scientific Officer | Option exercise | +6,114 | $2.69 | $16K | 302,059 |
| 2022-05-13 | Kanner Steven Chief Scientific Officer | Option exercise · Option to purchase Common Stock | −68,306 | 3,534 | ||
| 2022-05-13 | Kanner Steven Chief Scientific Officer | Option exercise · Option to purchase Common Stock | −6,114 | 116,849 | ||
| 2022-03-04 | Kanner Steven Chief Scientific Officer | Option exercise | +9,171 | $2.69 | $25K | 226,090 |
| 2022-03-04 | Kanner Steven Chief Scientific Officer | Option exercise | +1,549 | $4.11 | $6K | 227,639 |
| 2022-03-04 | Kanner Steven Chief Scientific Officer | Option exercise · Option to purchase Common Stock | −9,171 | 122,963 |
Page 1 of 2 · 28 trades